Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan
Journal of Clinical Laboratory Analysis · 2026
DOI: 10.1002/jcla.70286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2026. Verfasst von Hiroko Setoyama und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Hepatitis C, Triage, Hepacivirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Roche Diagnostics.
Abstract (Originalsprache)
Background
In Japan, the hepatitis C virus (HCV) care cascade is constrained at the transition from anti‐HCV antibody screening to confirmatory HCV ribonucleic acid (HCV RNA) testing in nonspecialist departments. As HCV prevalence declines and the population ages, the two‐step antibody‐to‐RNA algorithm becomes less efficient and vulnerable to loss to follow‐up. We evaluated whether the Elecsys HCV Duo assay could function as a triage test to strengthen linkage to care.
Methods
We conducted a two‐part study in Kumamoto Prefecture, Japan. First, a survey of 19 specialized institutions assessed hepatitis virus testing practices and downstream evaluation in nonspecialist departments. Second, 479 serum samples from patients undergoing HCV RNA quantification at four hospitals were prospectively evaluated using the Elecsys HCV Duo assay, with detection rates stratified by viral load.
Results
Nonspecialist departments accounted for 86.6% of in‐hospital anti‐HCV testing; however, among 1416 anti‐HCV–positive individuals identified outside gastroenterology departments, only 22.7% underwent confirmatory HCV RNA testing. In the prospective evaluation of 479 samples, HCVcAg sensitivity and specificity versus HCV RNA were 62.8% and 99.8%, respectively. Detection rates increased with viral load, from 0% at ≤ 4.0 log 10 IU/mL to 16.7% at 4.1–5.5 log 10 IU/mL and 86.2% at ≥ 5.6 log 10 IU/mL.
Conclusion
A vulnerability in the HCV care cascade lies at the transition from screening to confirmatory evaluation in nonspecialist settings. When implemented as a triage test within referral pathways, the Elecsys HCV Duo assay may improve linkage to specialist care while reserving HCV RNA testing for downstream confirmation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Gastroenterology and Hepatology, Kumamoto Shinto General Hospital, Kumamoto, Japan.
- National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
- Saiseikai Kumamoto Hospital, Kumamoto, Japan.
- Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
- Kumamoto Rosai Hospital, Kumamoto, Japan.
ORCID-Profile: Hiroko Setoyama, Takehisa Watanabe, Kentaro Matsuura, Yasuhito Tanaka
Förderung
- Japan Agency for Medical Research and Development
- Roche Diagnostics
Zitieren
APA
Setoyama, H., Watanabe, T., Miyase, S., Tateyama, M., Tanaka, M., Minami, N., Sasaki, M., Hashigo, S., Fukubayashi, K., Ishii, S., Koga, M., Ichikawa, R., Iwashita, H., Sakai, Y., Motohara, T., Tomita, K., Nakata, A., Kai, Y., Kounoe, T., …, & Tanaka, Y. (2026). Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70286
Vancouver
Setoyama H, Watanabe T, Miyase S, Tateyama M, Tanaka M, Minami N, et al. Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70286
BibTeX
@article{Setoyama2026,
author = {Setoyama, Hiroko and Watanabe, Takehisa and Miyase, Shiho and Tateyama, Masakuni and Tanaka, Motohiko and Minami, Nobuhiro and Sasaki, Masato and Hashigo, Shunpei and Fukubayashi, Kotaro and Ishii, Shotaro and Koga, Mutsuo and Ichikawa, Ryo and Iwashita, Hirofumi and Sakai, Yoshinari and Motohara, Toshihiko and Tomita, Kohei and Nakata, Akinori and Kai, Yutaka and Kounoe, Takeyasu and Haraoka, Katsuki and Inoue, Takako and Suzuki, Takanori and Matsuura, Kentaro and Tanaka, Yasuhito},
title = {Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
doi = {10.1002/jcla.70286}
}
EUVIMED